Palmitoyl Tripeptide-5

CosmeticCosmetic TGF-β mimetic tripeptideExperimental

Also known as: Pal-KVK, Syn-Coll

Palmitoyl Tripeptide-5 (also called Pal-KVK or Syn-Coll) is a cosmetic TGF-β mimetic tripeptide in the Matrix / Angiogenic class. Palmitoyl tripeptide-5 is a lipidated tripeptide used topically for effects on dermal collagen.

Calculate Dose

For research use only.

Key Facts

CAS
623172-55-4
Molecular Weight (MW)
—
Half-life
Topical; systemic PK not established
FDA status
Not Approved
Evidence level
Insufficient Evidence
Human dose established
No
Administration Route
Not established in humans
Frequency
Not established in humans
Last updated
Nov 7, 2026
Reviewed
Nov 7, 2026
Targets
TGF-β pathway (claimed)Collagen I

Research summary

Lipidated tripeptide marketed under the Syn-Coll name and used topically in firming and anti-ageing formulations. It is described as a thrombospondin-1 mimetic, intended to promote activation of transforming growth factor beta already present in the dermis rather than to supply new growth factor. Evidence comes predominantly from supplier research and small cosmetic studies. A cosmetic active, not a drug, and not FDA-approved.

Research evidence

  • Regulatory review (FDA label)None in reviewed sources
  • Controlled human trialsNone in reviewed sources
  • Early or uncontrolled human studies1 reviewed source
  • Lab & animal studiesNone in reviewed sources
How it works

Each step shows whether the sources Peptide Library has reviewed include that kind of research. Counts are reviewed sources, not every study ever published. Reviews and programme summaries that describe human use are shown as "reported", not as trials, and registered trials without published results are listed but not counted. A higher step means research has progressed further; it does not mean a compound works better or is safer. Compounds whose evidence has not been reviewed yet show "Not reviewed" instead of a guess.

Peptide Library's Palmitoyl Tripeptide-5 profile summarises 5 cited studies listed in the Science section, the compound's regulatory status, and research-protocol parameters reported for it. It is a research reference, not medical advice.

Palmitoyl Tripeptide-5 dosage: no established human dose

Palmitoyl tripeptide-5 (Syn-Coll) has no established human dosage. It is a cosmetic ingredient, and no controlled human study of it alone could be found. The only human study found is an open 12-week study of a microneedle patch that combined it with several other actives.

Insufficient Evidence

No established human dosage.

Human clinical evidence: None identified.

Preclinical research: Palmitoyl tripeptide-5 is a lipid-linked tripeptide used in anti-ageing cosmetics. Published work on it is mainly formulation science and supplier data. No controlled human study of it alone and no human study by injection could be found, so neither a topical strength nor an injected amount is established.

Animal dosing is not converted into a human dose anywhere on this page. Where research figures appear below, they are reported as studied, not recommended.

Dosage evidence summary for Palmitoyl Tripeptide-5
Human dosing establishedNo
RouteTopical (cosmetic use); not established for injection
Evidence levelInsufficient Evidence
Last reviewed2026-11-07

Human research reported

Doses as studied, one row per regimen. Different trials used different regimens; they are listed separately rather than averaged.

Research-reported dosing for Palmitoyl Tripeptide-5, one row per studied regimen
Study / contextPopulationDoseRouteFrequencyDurationOutcome studiedSource
Open clinical study — hyaluronic acid microneedle patch (Avcil et al., 2020)Clinical trial · Single-centre study of a multi-ingredient product, no stated control groupHealthy adults with aged skin (number not stated in the indexed abstract)Not stated in the indexed abstract; the patch combined arginine/lysine polypeptide, acetyl octapeptide-3, palmitoyl tripeptide-5, adenosine and seaweed extractsTopical (microneedle patch at the outer eye corners and the forearm)—12 weeksFine lines and wrinkles 25.8% lower, hydration 15.4% higher, dermal density and thickness 14.2% and 12.9% higher; no skin reactionsAvcil M et al. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study. J Cosmet Dermatol. 2020.
Review — peptides in cosmetics for sensitive skin (Resende et al., 2021)Research-reported · Narrative review and product survey88 facial products for sensitive skin from multinational brands (a product survey, not a study of people)Not applicableTopical products——Palmitoyl tripeptide-5 was one of seven peptides found; the authors note that the supporting data are mostly in patents and supplier brochures, not randomised placebo-controlled studiesResende DISP et al. Usage of Synthetic Peptides in Cosmetics for Sensitive Skin. Pharmaceuticals (Basel). 2021.

Where sources disagree

  • A percentage or ppm in a cream is a formulation strength, not a dose, and cannot be converted into an amount for injection.
  • Results from a product that contains several actives cannot be credited to palmitoyl tripeptide-5 alone.

Sequence & molecular data

Sequence and molecular data for Palmitoyl Tripeptide-5
Molecular formulaC33H65N5O5
Molecular weight—
CAS number623172-55-4
Half-lifeTopical; systemic PK not established
AppearanceWhite powder
FormulationTopical Cream
PubChem CID11950477

Identifiers link to the public PubChem, FDA Substance Registration (UNII), ChEMBL and DrugBank records for the same entity.

Science

Mechanism of Action

Palmitoyl tripeptide-5 is a lipidated tripeptide used topically for effects on dermal collagen. It is described as a mimetic of thrombospondin-1, the endogenous activator of latent transforming growth factor beta, and the proposed mechanism is that it promotes conversion of latent TGF-beta already present in the dermis into its active form rather than supplying new growth factor. Active TGF-beta drives fibroblast collagen synthesis. The evidence is predominantly supplier research and small cosmetic studies; independent controlled trials of the isolated peptide have not been published, and topical penetration remains the general constraint for peptides of this size.

Origin

Synthetic palmitoylated tripeptide.

Targets

TGF-β pathway (claimed)Collagen I

Research statistics

4 PubMed publications · 75.0% human clinical research · 0 registered trials

Counts of published research through 2026-11-15, not evidence that it works. Publications by year, study types and trials · How publications are counted

Regulatory & research status

Palmitoyl Tripeptide-5 is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.

Regulatory and research status for Palmitoyl Tripeptide-5
FDA statusNot Approved
AvailabilityOTC / Supplement
WADA (sport)Permitted
Library classificationResearch-Only

How FDA approval, compounding and research-only status differ

Benefits

Firmness-claim cosmetics

Palmitoyl Tripeptide-5 side effects

Palmitoyl Tripeptide-5 has no controlled human safety data. The effects below are reported, not established, and absence from the list is not evidence of safety.

Side Effects

  • Irritation

Storage & stability

This compound is not supplied as a powder to be mixed, so the freeze-dried powder and reconstitution handling described for research peptides does not apply. Storage conditions are product-specific: follow the label or packaging of the product itself.

Palmitoyl Tripeptide-5: frequently asked questions

What is Palmitoyl Tripeptide-5?

Lipidated tripeptide marketed under the Syn-Coll name and used topically in firming and anti-ageing formulations. It is described as a thrombospondin-1 mimetic, intended to promote activation of transforming growth factor beta already present in the dermis rather than to supply new growth factor. Evidence comes predominantly from supplier research and small cosmetic studies. A cosmetic active, not a drug, and not FDA-approved.

How does Palmitoyl Tripeptide-5 work?

Palmitoyl tripeptide-5 is a lipidated tripeptide used topically for effects on dermal collagen. It is described as a mimetic of thrombospondin-1, the endogenous activator of latent transforming growth factor beta, and the proposed mechanism is that it promotes conversion of latent TGF-beta already present in the dermis into its active form rather than supplying new growth factor.

Is Palmitoyl Tripeptide-5 FDA approved?

No. Palmitoyl Tripeptide-5 is not approved by the FDA for any indication and is categorised as otc / supplement. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use.

What is the half-life of Palmitoyl Tripeptide-5?

Reported half-life for Palmitoyl Tripeptide-5 is Topical; systemic PK not established. Half-life describes how long the compound persists in circulation, not how long any effect lasts, and published figures vary with route of administration, formulation and the population studied.

Is Palmitoyl Tripeptide-5 banned in sport?

Palmitoyl Tripeptide-5 is recorded here as permitted in sport. Anti-doping status is revised annually, so athletes subject to testing should confirm against the current WADA Prohibited List before use.

What peptides are similar to Palmitoyl Tripeptide-5?

Compounds most often compared with Palmitoyl Tripeptide-5 include Palmitoyl Pentapeptide-4, Palmitoyl Tetrapeptide-7, Acetyl Hexapeptide-8 and Acetyl Octapeptide-3. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

References

Related research, comparisons & guides

Related peptides

Compiled by Peptide Library Editorial · Reviewed Aug 30, 2026 · Updated Nov 7, 2026 · Version 2

This Palmitoyl Tripeptide-5 profile is compiled from published literature (5 cited studies linked above), public regulatory records and chemical registries. It describes what research reports; it is not medical advice, and nothing here is a dosing recommendation for humans. Peptide Library does not sell peptides. Editorial policy · How profiles are compiled · Report an error

Track Palmitoyl Tripeptide-5 research, inventory and reconstitution in the free Peptide Library app. Get the app for iOS or Android →